Study of Safety and Tolerability of PCI-27483 in Patients With Pancreatic Cancer Patients Receiving Treatment With Gemcitabine

Sponsor and Collaborators     

Michelle Stevens-Brogan, BS,MS     
[email protected]  
TGen Clinical Reserch Services at Scottsdale Healthcare
Scottsdale, Arizona, United States, 85258
Contact: Lisa Blaydorn, RN     480-323-1562     [email protected]    
Principal Investigator: Ramesh K. Ramanathan, MD            

Continue Reading

Pacific Cancer Medical Center     
Anaheim, California, United States, 92081
Contact: Elizabeth Garcia     714-999-1465 ext 240     [email protected]    
Principal Investigator: Venna Charu, MD            

Space Coast Medical Associates     
Titusville, Florida, United States, 32796
Contact: Terry McFarland, BSN     321-268-4200 ext 3168     [email protected]    
Principal Investigator: Firas Muwalla, MD            

Investigative Clinical Research of Indiana     
Indianapolis, Indiana, United States, 46260
Contact: Heather Rather, BS, CCRP     317-297-1136     [email protected]    
Contact: Kimberly Van Norn, CCRP     317-297-1136     [email protected]    
Principal Investigator: Robert Manges, MD            

Kenthucky Cancer Clinic     
Hazard, Kentucky, United States, 41701
Contact: Tracie McDaniel     606-439-2239     [email protected]    
Principal Investigator: Hassan Ghazal, MD            

Park Nicollet Institute     
St. Louis Park, Minnesota, United States, 55426
Contact: Laura Maybon     952-993-5710     [email protected]    
Contact: Karen Swenson     952-993-6071     [email protected]    
Principal Investigator: Michaela Tsai, MD            

Beth Israel Cancer Center     
New York, New York, United States, 10003
Contact: Damien Francois     212-844-8070     [email protected]    
Principal Investigator: Peter Kozuch, MD
Columbia University     (Active, not recruiting)
New York, New York, United States, 10032
University of Rochester     Recruiting
Rochester, New York, United States, 14642
Contact: Charcy Salamone     585-273-5474     [email protected]    
Principal Investigator: Alok Khorana, MD            

Summa Health System     
Akron, Ohio, United States, 44304
Contact: Joyce Neading     330-375-4221     [email protected]    
Contact: Ann Stone     330-375-6578     [email protected]    
Principal Investigator: Sameer Mahesh, MD
Gabrail Cancer Center Research     
Canton, Ohio, United States, 44718
Contact: Carrie Smith, R.N.     330-492-3345     [email protected]    
Contact: Amber Miller     330-492-3345 ext 213     [email protected]    
Principal Investigator: Nashat Gabrail, MD            

Gettysburg Cancer Center     
Gettysburg, Pennsylvania, United States, 17325
Contact: Vanessa Hardman     717-334-4033     [email protected]    
Principal Investigator: Satish Shah, MD            

Charleston Hematology Oncology Associates     
Charleston, South Carolina, United States, 29414
Contact: Deborah McNeal, RN, OCN     843-266-2540     [email protected]    
Contact: Susan Gibson, RN, OCN     843-266-0694     [email protected]    
Principal Investigator: George F Geils Jr, MD            

South Carolina Cancer Specialists, PA     
Hilton Head, South Carolina, United States, 29926
Contact: Becky McCunn     843-689-2895 ext 30     [email protected]    
Contact: Teressa Williams     843-689-9267     [email protected]    
Principal Investigator: Gary Thomas, MD            

Associates in Oncology and Hematology     
Chattanooga, Tennessee, United States, 37404
Contact: Jill Metcalf, CCRP     423-622-2337     [email protected]    
Contact: Jillian Mitchell     423-622-2337     [email protected]    
Principal Investigator: Jitendra G Ghandi, MD            

Sammons Cancer Center     
Dallas, Texas, United States, 75246
Contact: Claire Peterson     214-370-1949     [email protected]    
Contact: Jonathan Huntzinger     214-370-1900        
Principal Investigator: Carlos Becerra, MD            

University of Vermont/Vermont Cancer Center     
Burlington, Vermont, United States, 05401
Contact: Karen Lepuschenko     802-656-9925     [email protected]    
Principal Investigator: Steven Ades, MD Identifier